Epidermal Growth Factor Receptor Inhibitor Market 2027 By Product Type, and Geography | The Insight Partners

Epidermal Growth Factor Receptor Inhibitor Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (Lung Cancer, Colorectal Cancer, Breast Cancer, Others. On the basis of treatment, the market is categorized as Hospital and Clinics, Research Institutes and Institutions, Other), and Geography

Report Code: TIPRE00015595 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

The epidermal growth factor (EGFR) receptor is a transmembrane tyrosine kinase receptor that contributes to the survival and spread of cancer cells. Any form of EFGR receptor or activity mutation may lead to cancer. Cutures contribute to over-expression of the disease, such as lung cancer, anal cancer and multiforme glioblastoma.

MARKET DYNAMICS

Cases like increased geriatric populations and shifting lifestyles can be attributed to this growing incidence of cancer. Increased designation of special drugs and high efficacy of EGFR inhibitors will lead to rapid clinical approval of signs of cancer such as lung cancer, colorectal cancer and breast cancer. Thus, the strong prevalence of major cancer indications is a significant factor driving epidermal growth factor receptor inhibitors.

MARKET SCOPE

The "Epidermal Growth Factor Receptor Inhibitor Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Epidermal Growth Factor Receptor Inhibitor Market with detailed market segmentation by product type, and application. The Epidermal Growth Factor Receptor Inhibitor Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Epidermal Growth Factor Receptor Inhibitor Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Epidermal Growth Factor Receptor Inhibitor Market is segmented on the basis of type, and end use. Based on type, the market is segmented as Lung Cancer, Colorectal Cancer, Breast Cancer, Others. On the basis of treatment, the market is categorized as Hospital and Clinics, Research Institutes and Institutions, Other.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Epidermal Growth Factor Receptor Inhibitor Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Epidermal Growth Factor Receptor Inhibitor Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Epidermal Growth Factor Receptor Inhibitor Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Epidermal Growth Factor Receptor Inhibitor Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Epidermal Growth Factor Receptor Inhibitor Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Epidermal Growth Factor Receptor Inhibitor Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Epidermal Growth Factor Receptor Inhibitor Market in the global market. Below mentioned is the list of few companies engaged in the Epidermal Growth Factor Receptor Inhibitor Market.

The report also includes the profiles of key players in Epidermal Growth Factor Receptor Inhibitor Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   AstraZeneca
  •   Roche
  •   Pfizer Inc.
  •   Spectrum Pharmaceuticals, Inc.
  •   CULLINAN ONCOLOGY, LLC
  •   TAIHO PHARMACEUTICAL
  •   Lutris Pharma
  •   Boehringer Ingelheim International GmbH
  •   Puma Biotechnology
  •   Apollomics, Inc.
  •   Hutchison MediPharma Limited

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Epidermal Growth Factor Receptor Inhibitor Market - By Type
1.3.2 Epidermal Growth Factor Receptor Inhibitor Market - By Application
1.3.3 Epidermal Growth Factor Receptor Inhibitor Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR MARKET - GLOBAL MARKET ANALYSIS
6.1. EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR - GLOBAL MARKET OVERVIEW
6.2. EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. LUNG CANCER
7.3.1. Overview
7.3.2. Lung Cancer Market Forecast and Analysis
7.4. COLORECTAL CANCER
7.4.1. Overview
7.4.2. Colorectal Cancer Market Forecast and Analysis
7.5. BREAST CANCER
7.5.1. Overview
7.5.2. Breast Cancer Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL AND CLINICS
8.3.1. Overview
8.3.2. Hospital and Clinics Market Forecast and Analysis
8.4. RESEARCH INSTITUTES AND INSTITUTIONS
8.4.1. Overview
8.4.2. Research Institutes and Institutions Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis
9. EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Epidermal Growth Factor Receptor Inhibitor Market Overview
9.1.2 North America Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis
9.1.3 North America Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis - By Type
9.1.4 North America Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis - By Application
9.1.5 North America Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis - By Countries
9.1.5.1 United States Epidermal Growth Factor Receptor Inhibitor Market
9.1.5.1.1 United States Epidermal Growth Factor Receptor Inhibitor Market by Type
9.1.5.1.2 United States Epidermal Growth Factor Receptor Inhibitor Market by Application
9.1.5.2 Canada Epidermal Growth Factor Receptor Inhibitor Market
9.1.5.2.1 Canada Epidermal Growth Factor Receptor Inhibitor Market by Type
9.1.5.2.2 Canada Epidermal Growth Factor Receptor Inhibitor Market by Application
9.1.5.3 Mexico Epidermal Growth Factor Receptor Inhibitor Market
9.1.5.3.1 Mexico Epidermal Growth Factor Receptor Inhibitor Market by Type
9.1.5.3.2 Mexico Epidermal Growth Factor Receptor Inhibitor Market by Application
9.2. EUROPE
9.2.1 Europe Epidermal Growth Factor Receptor Inhibitor Market Overview
9.2.2 Europe Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis
9.2.3 Europe Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis - By Type
9.2.4 Europe Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis - By Application
9.2.5 Europe Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Epidermal Growth Factor Receptor Inhibitor Market
9.2.5.1.1 Germany Epidermal Growth Factor Receptor Inhibitor Market by Type
9.2.5.1.2 Germany Epidermal Growth Factor Receptor Inhibitor Market by Application
9.2.5.2 France Epidermal Growth Factor Receptor Inhibitor Market
9.2.5.2.1 France Epidermal Growth Factor Receptor Inhibitor Market by Type
9.2.5.2.2 France Epidermal Growth Factor Receptor Inhibitor Market by Application
9.2.5.3 Italy Epidermal Growth Factor Receptor Inhibitor Market
9.2.5.3.1 Italy Epidermal Growth Factor Receptor Inhibitor Market by Type
9.2.5.3.2 Italy Epidermal Growth Factor Receptor Inhibitor Market by Application
9.2.5.4 Spain Epidermal Growth Factor Receptor Inhibitor Market
9.2.5.4.1 Spain Epidermal Growth Factor Receptor Inhibitor Market by Type
9.2.5.4.2 Spain Epidermal Growth Factor Receptor Inhibitor Market by Application
9.2.5.5 United Kingdom Epidermal Growth Factor Receptor Inhibitor Market
9.2.5.5.1 United Kingdom Epidermal Growth Factor Receptor Inhibitor Market by Type
9.2.5.5.2 United Kingdom Epidermal Growth Factor Receptor Inhibitor Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Epidermal Growth Factor Receptor Inhibitor Market Overview
9.3.2 Asia-Pacific Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis
9.3.3 Asia-Pacific Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Epidermal Growth Factor Receptor Inhibitor Market
9.3.5.1.1 Australia Epidermal Growth Factor Receptor Inhibitor Market by Type
9.3.5.1.2 Australia Epidermal Growth Factor Receptor Inhibitor Market by Application
9.3.5.2 China Epidermal Growth Factor Receptor Inhibitor Market
9.3.5.2.1 China Epidermal Growth Factor Receptor Inhibitor Market by Type
9.3.5.2.2 China Epidermal Growth Factor Receptor Inhibitor Market by Application
9.3.5.3 India Epidermal Growth Factor Receptor Inhibitor Market
9.3.5.3.1 India Epidermal Growth Factor Receptor Inhibitor Market by Type
9.3.5.3.2 India Epidermal Growth Factor Receptor Inhibitor Market by Application
9.3.5.4 Japan Epidermal Growth Factor Receptor Inhibitor Market
9.3.5.4.1 Japan Epidermal Growth Factor Receptor Inhibitor Market by Type
9.3.5.4.2 Japan Epidermal Growth Factor Receptor Inhibitor Market by Application
9.3.5.5 South Korea Epidermal Growth Factor Receptor Inhibitor Market
9.3.5.5.1 South Korea Epidermal Growth Factor Receptor Inhibitor Market by Type
9.3.5.5.2 South Korea Epidermal Growth Factor Receptor Inhibitor Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Epidermal Growth Factor Receptor Inhibitor Market Overview
9.4.2 Middle East and Africa Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis
9.4.3 Middle East and Africa Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Epidermal Growth Factor Receptor Inhibitor Market
9.4.5.1.1 South Africa Epidermal Growth Factor Receptor Inhibitor Market by Type
9.4.5.1.2 South Africa Epidermal Growth Factor Receptor Inhibitor Market by Application
9.4.5.2 Saudi Arabia Epidermal Growth Factor Receptor Inhibitor Market
9.4.5.2.1 Saudi Arabia Epidermal Growth Factor Receptor Inhibitor Market by Type
9.4.5.2.2 Saudi Arabia Epidermal Growth Factor Receptor Inhibitor Market by Application
9.4.5.3 U.A.E Epidermal Growth Factor Receptor Inhibitor Market
9.4.5.3.1 U.A.E Epidermal Growth Factor Receptor Inhibitor Market by Type
9.4.5.3.2 U.A.E Epidermal Growth Factor Receptor Inhibitor Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Epidermal Growth Factor Receptor Inhibitor Market Overview
9.5.2 South and Central America Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis
9.5.3 South and Central America Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis - By Type
9.5.4 South and Central America Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis - By Application
9.5.5 South and Central America Epidermal Growth Factor Receptor Inhibitor Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Epidermal Growth Factor Receptor Inhibitor Market
9.5.5.1.1 Brazil Epidermal Growth Factor Receptor Inhibitor Market by Type
9.5.5.1.2 Brazil Epidermal Growth Factor Receptor Inhibitor Market by Application
9.5.5.2 Argentina Epidermal Growth Factor Receptor Inhibitor Market
9.5.5.2.1 Argentina Epidermal Growth Factor Receptor Inhibitor Market by Type
9.5.5.2.2 Argentina Epidermal Growth Factor Receptor Inhibitor Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ROCHE
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SPECTRUM PHARMACEUTICALS, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CULLINAN ONCOLOGY, LLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. TAIHO PHARMACEUTICAL
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LUTRIS PHARMA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PUMA BIOTECHNOLOGY, INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. APOLLOMICS, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11. HUTCHISON MEDIPHARMA LIMITED
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AstraZeneca
2. Roche
3. Pfizer Inc.
4. Spectrum Pharmaceuticals, Inc.
5. TAIHO PHARMACEUTICAL
6. Lutris Pharma
7. Boehringer Ingelheim International GmbH
8. Puma Biotechnology
9. Apollomics, Inc.
10. Hutchison
TIPRE00015595
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking